BioSpace News Archive

According to the report, the global medical device & IVD regulatory affairs outsourcing market was valued at US$ 1.03 Bn in 2019.

Inductively Coupled Plasma Mass Spectroscopy is abbreviated to ICP-MS. This system refers to a form of mass spectroscopy, which comes with the ability to detect various non-metal and metals in extremely low concentrations, such as one PPQ.

Blood transfusion is one of the important processes performed in healthcare sector. In this process, the blood and blood components are transfused into the patient’s body to restore blood components lost during surgeries or due to various blood-related health conditions.

The global antiseptic and disinfectant market may incur phenomenal growth between 2019 and 2029 on the grounds of the novel coronavirus outbreak.

Allergies are prevalent in large numbers around the world. To tackle these allergies, a plethora of developments are taking place and have taken place earlier, bringing immense growth opportunities for the allergy treatment market.

Molecular Partners AG, a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, announced supportive preclinical data from in vivo assessments of its DARPin® candidates targeting SARS-CoV-2.

Transgene, NEC Corporation, and BostonGene Corporation announced a strategic collaboration for two ongoing Phase 1 clinical trials of TG4050, an individualized therapeutic vaccine for ovarian and head & neck cancers based on Transgene’s proprietary myvac® platform and NEC’s AI-driven Neoantigen Prediction System in Europe and the United States.

Syngenta Group announces the acquisition of Valagro, a leading Biologicals company, by its business unit Syngenta Crop Protection.

Hemogenyx Pharmaceuticals plc, the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce the following update on its activities.

Halozyme Therapeutics, Inc. announced that Halozyme and argenx are expanding their existing global collaboration and license agreement that was signed in February 2019.